Gene: DENND4B
Official Full Name: DENN domain containing 4Bprovided by HGNC
Gene Summary: Enables guanyl-nucleotide exchange factor activity. Involved in regulation of Rab protein signal transduction. Located in Golgi apparatus and nucleoplasm. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO02268 | DENND4B Knockout cell line (HeLa) | Human | DENND4B | 1:3~1:6 | Negative | Online Inquiry |
KO02269 | DENND4B Knockout cell line (HCT 116) | Human | DENND4B | 1:2~1:4 | Negative | Online Inquiry |
KO02270 | DENND4B Knockout cell line (HEK293) | Human | DENND4B | 1:3~1:6 | Negative | Online Inquiry |
KO02271 | DENND4B Knockout cell line (A549) | Human | DENND4B | 1:3~1:4 | Negative | Online Inquiry |
DENND4B Gene Knockout Cell Lines are genetically modified cell lines designed to facilitate the functional analysis of the DENND4B gene, which is implicated in processes such as endocytosis and vesicle trafficking. These cell lines allow researchers to investigate the gene's role in various biological mechanisms by completely inhibiting its expression. The knockout technique relies on CRISPR-Cas9 technology, ensuring precise editing and reliable outcomes in the targeted cells.
The primary function of DENND4B is to act as a guanine nucleotide exchange factor (GEF), which plays a crucial role in activating RAB GTPases that regulate intracellular trafficking pathways. By knocking out this gene, researchers can directly observe the resultant phenotypic changes in cellular function and morphology, providing insights into its contribution to cellular processes and its potential role in disease states.
The scientific importance of DENND4B Gene Knockout Cell Lines extends beyond fundamental research; they are invaluable in preclinical studies focused on drug discovery and translational medicine. Understanding how DENND4B influences signaling pathways can lead to identifying novel therapeutic targets, particularly in disorders associated with cellular transport dysfunction, such as cancer and neurodegeneration.
Compared to traditional methods such as RNA interference, which often lead to incomplete knockdown and compensatory effects, our DENND4B Gene Knockout Cell Lines provide a full and stable knockout of the gene. This specificity enhances the robustness and reproducibility of experimental results, making them more reliable for publication and future applications.
For researchers and clinicians seeking to advance their studies on vesicle trafficking or explore innovative therapeutic approaches, DENND4B Gene Knockout Cell Lines present a high-value tool. They cater to an advancing field that necessitates precise gene editing methodologies, ultimately supporting breakthroughs in biomedical research.
Our company specializes in cutting-edge genetic modifications, and our commitment to quality and innovation ensures that our DENND4B Gene Knockout Cell Lines are a trustworthy asset for your research needs. We take pride in delivering products that enhance scientific discovery and contribute to the success of our partners in the research community.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.